Page last updated: 2024-11-07

spironolactone and Exanthem

spironolactone has been researched along with Exanthem in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Le-Rademacher, JG1
Rowland, K1
Atherton, PJ1
Dakhil, C1
Sun, Z1
Tan, A1
Schmidt, L1
Nguyen, PL1
Radecki Breitkopf, C1
Pittelkow, M1
Tindall, D1
Menon, S1
Jatoi, A1

Trials

1 trial available for spironolactone and Exanthem

ArticleYear
Androgen Mediation-and Antiandrogens Mitigation-of the Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash: Results From a Pilot Randomized Trial and Small Translational Case Series.
    The American journal of hospice & palliative care, 2019, Volume: 36, Issue:6

    Topics: Adult; Aged; Androgen Antagonists; Biopsy; Double-Blind Method; ErbB Receptors; Exanthema; Female; H

2019